DZ Bank
EGRX

DZ Bank’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

DZ Bank’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-166,203
Closed -$4.72M – 1122
2023
Q1 		$4.72M Sell
166,203
-63,668
-28% -$1.89M 0.01% 462
2022
Q4 		$6.72M Sell
229,871
-55,740
-20% -$1.77M 0.01% 405
2022
Q3 		$7.55M Sell
285,611
-8,383
-3% -$308K 0.01% 368
2022
Q2 		$13.1M Buy
293,994
+122,898
+72% +$5.64M 0.02% 279
2022
Q1 		$8.47M Buy
171,096
+165,770
+3,112% +$7.96M 0.01% 394
2021
Q4 		$271K Hold
5,326
– – ﹤0.01% 861
2021
Q3 		$297K Buy
+5,326
New +$262K ﹤0.01% 817
2020
Q2 		– Sell
-4,352
Closed -$200K – 862
2020
Q1 		$200K Buy
4,352
+1,003
+30% +$50.3K ﹤0.01% 657
2019
Q4 		$201K Sell
3,349
-1,003
-23% -$59.8K ﹤0.01% 637
2019
Q3 		$246K Sell
4,352
-98,716
-96% -$5.55M ﹤0.01% 654
2019
Q2 		$5.74M Sell
103,068
-2,530
-2% -$132K 0.02% 345
2019
Q1 		$5.33M Buy
105,598
+6,140
+6% +$273K 0.02% 349
2018
Q4 		$3.9M Sell
99,458
-13,499
-12% -$696K 0.02% 383
2018
Q3 		$7.83M Sell
112,957
-9,477
-8% -$718K 0.03% 303
2018
Q2 		$9.26M Buy
122,434
+521
+0.4% +$32.8K 0.03% 290
2018
Q1 		$6.42M Buy
121,913
+29,166
+31% +$1.7M 0.02% 355
2017
Q4 		$4.95M Buy
92,747
+3,086
+3% +$172K 0.02% 375
2017
Q3 		$5.35M Buy
+89,661
New +$5.42M 0.02% 361

Other funds holding EGRX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

DZ Bank's EGRX Position: Q2 2023 in Review

DZ Bank sold out of Eagle Pharmaceuticals, Inc. (EGRX) in Q2 2023, closing a stake of 166,203 shares — an estimated $4.72M sold.

DZ Bank first reported a position in EGRX in Q3 2017 and held it in 18 quarters. The position peaked at $13.1M in Q2 2022. 126 funds tracked by Wall St. Rank hold EGRX as of Q2 2023.

  • DZ Bank reported no remaining Eagle Pharmaceuticals, Inc. position as of Q2 2023 after selling out during the quarter.
  • DZ Bank sold 166,203 Eagle Pharmaceuticals, Inc. shares in Q2 2023, an estimated $4.72M.
  • DZ Bank first reported a position in Eagle Pharmaceuticals, Inc. in Q3 2017 and held it in 18 quarters.
  • DZ Bank's Eagle Pharmaceuticals, Inc. position peaked at $13.1M in Q2 2022.
  • 126 funds tracked by Wall St. Rank held Eagle Pharmaceuticals, Inc. as of Q2 2023.

Based on DZ Bank's 13F filing for Q2 2023, filed 14 Aug 2023.